Log in to save to my catalogue

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc ana...

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc ana...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4984de67e7944ce78fa9ef64795d2b8b

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study

About this item

Full title

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study

Publisher

London: Nature Publishing Group UK

Journal title

NPJ primary care respiratory medicine, 2024-11, Vol.34 (1), p.34-10, Article 34

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

This post-hoc analysis of the SABINA III study evaluated the association of short-acting β
2
-agonist (SABA) prescriptions and self-reported over-the-counter (OTC) SABA purchase in the previous 12 months with asthma-related outcomes using multivariable regression models in 4556 patients (mean age, 48.9 years). Of the 2810 patients prescribed...

Alternative Titles

Full title

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4984de67e7944ce78fa9ef64795d2b8b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4984de67e7944ce78fa9ef64795d2b8b

Other Identifiers

ISSN

2055-1010

E-ISSN

2055-1010

DOI

10.1038/s41533-024-00397-4

How to access this item